TARDBP and neurodegenerative disease: To test the capabilities of MAVE-NN on less complete DMS datasets, we analyzed recent experiments on amyloid beta (Aβ) [9] and TDP-43 [10], both of which exhibit aggregation behavior in the context of neurodegenerative diseases.